Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.21 - $0.35 $5,562 - $9,270
-26,488 Reduced 10.1%
235,773 $54,000
Q4 2022

Feb 13, 2023

SELL
$0.22 - $0.41 $75,386 - $140,493
-342,666 Reduced 56.65%
262,261 $62,000
Q3 2022

Nov 14, 2022

SELL
$0.41 - $0.64 $7,093 - $11,072
-17,300 Reduced 2.78%
604,927 $234,000
Q2 2022

Aug 12, 2022

SELL
$0.42 - $0.65 $71,409 - $110,514
-170,023 Reduced 21.46%
622,227 $376,000
Q1 2022

May 16, 2022

SELL
$0.54 - $2.74 $12,300 - $62,414
-22,779 Reduced 2.79%
792,250 $477,000
Q4 2021

Feb 14, 2022

BUY
$2.33 - $3.37 $7,034 - $10,174
3,019 Added 0.37%
815,029 $2.18 Million
Q3 2021

Nov 15, 2021

SELL
$2.52 - $2.99 $93,287 - $110,686
-37,019 Reduced 4.36%
812,010 $2.24 Million
Q2 2021

Aug 16, 2021

BUY
$2.6 - $3.65 $276,361 - $387,969
106,293 Added 14.31%
849,029 $2.42 Million
Q1 2021

May 13, 2021

SELL
$2.73 - $4.5 $161,564 - $266,314
-59,181 Reduced 7.38%
742,736 $2.55 Million
Q4 2020

Feb 09, 2021

BUY
$2.6 - $3.32 $125,187 - $159,854
48,149 Added 6.39%
801,917 $2.12 Million
Q3 2020

Nov 05, 2020

BUY
$2.46 - $4.27 $216,666 - $376,084
88,076 Added 13.23%
753,768 $2.35 Million
Q2 2020

Aug 13, 2020

BUY
$1.45 - $4.3 $460,319 - $1.37 Million
317,462 Added 91.16%
665,692 $2.75 Million
Q1 2020

May 14, 2020

BUY
$0.75 - $2.55 $261,172 - $887,986
348,230 New
348,230 $561,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $373M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.